SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases

NCT06794086 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Liver Metastases

Interventions

RADIATION: Stereotactic body radiation therapy
DRUG: PD-1 Monoclonal Antibody
DRUG: Chemotherapy

Sponsor

Jun Huang